Novel antibody blocks Epstein-Barr virus, curing follicular lymphoma — and a plan to reduce cancer in Washington state
SEATTLE – March 4, 2026 – Below are summaries of recent Fred Hutch Cancer Center research findings, patient…
‘Search and destroy’ treatment halts incurable prostate cancer
A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer.…
Combination therapy may help overcome barrier in early-stage prostate cancer treatment
A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy…
Can a simple blood test improve seniors’ lives through earlier cancer detection?
Can a simple blood test improve the lives of seniors through early cancer detection? A three-year clinical trial…
Advanced AI provides accurate guidance for prostate cancer patients
Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large language model to provide accurate, patient-specific prostate cancer education. The…
Busting Prostate Cancer Myths: Facts Malaysian Men Should Know For Early Detection, Better Outcomes
KUALA LUMPUR, Dec 22 — Prostate cancer remains one of the most misunderstood cancers among Malaysian men, despite…
Sir Cliff Richard urges awareness following cancer treatment
UK pop star Sir Cliff Richard has revealed that he has been successfully treated for prostate cancer over…
Prostate Cancer Screening: Tests & Diagnosis from Fred Hutch
Good prostate cancer screening tests have led to early diagnosis in about 80% of men with the disease.…
Landmark prostate cancer screening trial launches in the UK
The first men have been invited to take part in Prostate Cancer UK’s TRANSFORM trial, kicking off the…
Study uncovers promising therapeutic strategies against neuroendocrine prostate cancer
A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer. McGill…
Age impacts systemic therapy outcomes in metastatic prostate cancer
Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new…
PTGES3 emerges as key regulator of androgen receptor in prostate cancer
A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player…